Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fushida

Showing results (51-60 of 110) with videos related to

Pageof 11
Sort By:
Hepato-Gastroenterology|May 6, 1999
A new surgical approach (peritonectomy) for the treatment of peritoneal disseminationY Yonemura, T Fujimura, S Fushida, et al.
Clinical & Experimental Metastasis|July 13, 2001
Membrane-type 1 matrix metalloproteinase enhances lymph node metastasis of gastric cancerY Yonemura, Y Endo, T Takino, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2001
Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancerY Yonemura, S Fushida, E Bando, et al.
World Journal of Surgery|July 1, 1991
Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal disseminationY Yonemura, T Fujimura, S Fushida, et al.
Cancer|June 1, 1991
Expression of c-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for c-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinomaY Yonemura, I Ninomiya, S Ohoyama, et al.
Cancer|January 1, 1990
Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operationT Fujimura, Y Yonemura, S Fushida, et al.
Cancer Chemotherapy and Pharmacology|February 21, 2013
Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosisS Fushida, J Kinoshita, M Kaji, et al.
Cancer|June 4, 1998
The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptorK Taniguchi, Y Yonemura, N Nojima, et al.
Transplantation Proceedings|November 25, 2010
Role of transcription factors in small intestinal ischemia-reperfusion injury and tolerance induced by ischemic preconditioningM Takeshita, T Tani, S Harada, et al.
Endoscopy|August 10, 2002
Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancerT Fujimura, S Kinami, I Ninomiya, et al.
Pageof 11

Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Hepato-Gastroenterology|May 6, 1999
A new surgical approach (peritonectomy) for the treatment of peritoneal disseminationY Yonemura, T Fujimura, S Fushida, et al.
Clinical & Experimental Metastasis|July 13, 2001
Membrane-type 1 matrix metalloproteinase enhances lymph node metastasis of gastric cancerY Yonemura, Y Endo, T Takino, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2001
Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancerY Yonemura, S Fushida, E Bando, et al.
World Journal of Surgery|July 1, 1991
Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal disseminationY Yonemura, T Fujimura, S Fushida, et al.
Cancer|June 1, 1991
Expression of c-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for c-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinomaY Yonemura, I Ninomiya, S Ohoyama, et al.
Cancer|January 1, 1990
Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operationT Fujimura, Y Yonemura, S Fushida, et al.
Cancer Chemotherapy and Pharmacology|February 21, 2013
Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosisS Fushida, J Kinoshita, M Kaji, et al.
Cancer|June 4, 1998
The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptorK Taniguchi, Y Yonemura, N Nojima, et al.
Transplantation Proceedings|November 25, 2010
Role of transcription factors in small intestinal ischemia-reperfusion injury and tolerance induced by ischemic preconditioningM Takeshita, T Tani, S Harada, et al.
Endoscopy|August 10, 2002
Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancerT Fujimura, S Kinami, I Ninomiya, et al.
Pageof 11